Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mario Cazzola

Blood

Showing results (1-10 of 71) with videos related to

Pageof 8
Sort By:
Blood|March 12, 2016
Mutant calreticulin: when a chaperone becomes intrusiveMario Cazzola
Blood|December 21, 2021
Ineffective erythropoiesis and its treatmentMario Cazzola
Blood|August 27, 2016
How I treat essential thrombocythemiaElisa Rumi, Mario Cazzola
Blood|December 29, 2016
Diagnosis, risk stratification, and response evaluation in classical myeloproliferative neoplasmsElisa Rumi, Mario Cazzola
Blood|May 3, 2014
From Janus kinase 2 to calreticulin: the clinically relevant genomic landscape of myeloproliferative neoplasmsMario Cazzola, Robert Kralovics
Blood|January 9, 2025
How I manage patients with unexplained cytopeniaLuca Malcovati, Mario Cazzola
Blood|July 14, 2022
Developing a classification of hematologic neoplasms in the era of precision medicineMario Cazzola, Laurie H Sehn
Blood|November 20, 2012
Biologic and clinical significance of somatic mutations of SF3B1 in myeloid and lymphoid neoplasmsMario Cazzola, Marianna Rossi, Luca Malcovati, et al.
Blood|October 19, 2013
The genetic basis of myelodysplasia and its clinical relevanceMario Cazzola, Matteo G Della Porta, Luca Malcovati
Blood|October 24, 2002
Absent phenotypic expression of X-linked sideroblastic anemia in one of 2 brothers with a novel ALAS2 mutationMario Cazzola, Alison May, Gaetano Bergamaschi, et al.
Pageof 8

Showing results (1-10 of 71) with videos related to

Sort By:
Pageof 8
Blood|March 12, 2016
Mutant calreticulin: when a chaperone becomes intrusiveMario Cazzola
Blood|December 21, 2021
Ineffective erythropoiesis and its treatmentMario Cazzola
Blood|August 27, 2016
How I treat essential thrombocythemiaElisa Rumi, Mario Cazzola
Blood|December 29, 2016
Diagnosis, risk stratification, and response evaluation in classical myeloproliferative neoplasmsElisa Rumi, Mario Cazzola
Blood|May 3, 2014
From Janus kinase 2 to calreticulin: the clinically relevant genomic landscape of myeloproliferative neoplasmsMario Cazzola, Robert Kralovics
Blood|January 9, 2025
How I manage patients with unexplained cytopeniaLuca Malcovati, Mario Cazzola
Blood|July 14, 2022
Developing a classification of hematologic neoplasms in the era of precision medicineMario Cazzola, Laurie H Sehn
Blood|November 20, 2012
Biologic and clinical significance of somatic mutations of SF3B1 in myeloid and lymphoid neoplasmsMario Cazzola, Marianna Rossi, Luca Malcovati, et al.
Blood|October 19, 2013
The genetic basis of myelodysplasia and its clinical relevanceMario Cazzola, Matteo G Della Porta, Luca Malcovati
Blood|October 24, 2002
Absent phenotypic expression of X-linked sideroblastic anemia in one of 2 brothers with a novel ALAS2 mutationMario Cazzola, Alison May, Gaetano Bergamaschi, et al.
Pageof 8